Table 4.
Linear regression of log PAT or log PAT/SAT ratio on GIR
| Model | Log PAT | Log PAT/SAT | |||
|---|---|---|---|---|---|
| Males (N=36) | Females (N=47) | p for log | (N=83) | p for log | |
| β (±SE)*, p-value | β (±SE)*, p-value | PAT* sex | β (±SE)*, p-value | PAT/SAT* sex | |
| Model 1† | −2.62 (±1.27), 0.051 | 0.05 (±1.05), 0.962 | 0.218 | −1.03 (±0.68), 0.136 | 0.782 |
| Model 2‡ | −1.03 (±1.46), 0.485 | −0.49 (±1.30), 0.707 | 0.201 | −1.35 (±0.70), 0.057 | 0.835 |
| Model 3§ | −1.33 (±1.78), 0.462 | 1.48 (±1.46), 0.320 | 0.111 | −0.96 (±0.74), 0.200 | 0.807 |
| Model 4|| | −0.18 (±2.38), 0.940 | 3.36 (±1.96), 0.097 | 0.055 | −2.08 (±1.03), 0.047 | 0.768 |
Abbreviations: PAT, pericardial adipose tissue; SAT, subcutaneous adipose tissue; GIR, glucose infusion rate; BMI, body mass index; VAT, visceral adipose tissue; LDL, low-density lipoprotein
Per 1 SD
Adjusted for diabetes, race, age, systolic blood pressure, LDL, log triglycerides, on blood pressure and lipid lowering medication, percent of energy from fats and carbohydrates, and square-root transformed minutes of moderate intensity-equivalent activity weekly; additionally adjusted for sex in log PAT/SAT ratio models
Adjusted for variables in Model 1 + BMI
Adjusted for variables in Model 2 + VAT
Adjusted for variables in Model 3 + log PAT/SAT ratio or log PAT, respectively